115 related articles for article (PubMed ID: 29415082)
1. SubID, a non-median dichotomization tool for heterogeneous populations, reveals the pan-cancer significance of INPP4B and its regulation by EVI1 in AML.
Dzneladze I; Woolley JF; Rossell C; Han Y; Rashid A; Jain M; Reimand J; Minden MD; Salmena L
PLoS One; 2018; 13(2):e0191510. PubMed ID: 29415082
[TBL] [Abstract][Full Text] [Related]
2. Correction: SubID, a non-median dichotomization tool for heterogeneous populations, reveals the pan-cancer significance of INPP4B and its regulation by EVI1 in AML.
PLOS ONE Staff
PLoS One; 2018; 13(3):e0195417. PubMed ID: 29596510
[TBL] [Abstract][Full Text] [Related]
3. INPP4B promotes cell survival via SGK3 activation in NPM1-mutated leukemia.
Jin H; Yang L; Wang L; Yang Z; Zhan Q; Tao Y; Zou Q; Tang Y; Xian J; Zhang S; Jing Y; Zhang L
J Exp Clin Cancer Res; 2018 Jan; 37(1):8. PubMed ID: 29343273
[TBL] [Abstract][Full Text] [Related]
4. IRF2-INPP4B axis participates in the development of acute myeloid leukemia by regulating cell growth and survival.
Zhang F; Zhu J; Li J; Zhu F; Zhang P
Gene; 2017 Sep; 627():9-14. PubMed ID: 28579269
[TBL] [Abstract][Full Text] [Related]
5. INPP4B overexpression is associated with poor clinical outcome and therapy resistance in acute myeloid leukemia.
Dzneladze I; He R; Woolley JF; Son MH; Sharobim MH; Greenberg SA; Gabra M; Langlois C; Rashid A; Hakem A; Ibrahimova N; Arruda A; Löwenberg B; Valk PJ; Minden MD; Salmena L
Leukemia; 2015 Jul; 29(7):1485-95. PubMed ID: 25736236
[TBL] [Abstract][Full Text] [Related]
6. Inositol polyphosphate 4-phosphatase II (INPP4B) is associated with chemoresistance and poor outcome in AML.
Rijal S; Fleming S; Cummings N; Rynkiewicz NK; Ooms LM; Nguyen NY; Teh TC; Avery S; McManus JF; Papenfuss AT; McLean C; Guthridge MA; Mitchell CA; Wei AH
Blood; 2015 Apr; 125(18):2815-24. PubMed ID: 25736313
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of the EVI1 gene expression in patients with acute myeloid leukemia: a meta-analysis.
Wu X; Wang H; Deng J; Zheng X; Ling Y; Gong Y
Ann Hematol; 2019 Nov; 98(11):2485-2496. PubMed ID: 31482295
[TBL] [Abstract][Full Text] [Related]
8. INPP4B-mediated DNA repair pathway confers resistance to chemotherapy in acute myeloid leukemia.
Wang P; Ma D; Wang J; Fang Q; Gao R; Wu W; Cao L; Hu X; Zhao J; Li Y
Tumour Biol; 2016 Sep; 37(9):12513-12523. PubMed ID: 27342972
[TBL] [Abstract][Full Text] [Related]
9. In Vivo Role of INPP4B in Tumor and Metastasis Suppression through Regulation of PI3K-AKT Signaling at Endosomes.
Li Chew C; Lunardi A; Gulluni F; Ruan DT; Chen M; Salmena L; Nishino M; Papa A; Ng C; Fung J; Clohessy JG; Sasaki J; Sasaki T; Bronson RT; Hirsch E; Pandolfi PP
Cancer Discov; 2015 Jul; 5(7):740-51. PubMed ID: 25883022
[TBL] [Abstract][Full Text] [Related]
10. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia.
Lugthart S; Gröschel S; Beverloo HB; Kayser S; Valk PJ; van Zelderen-Bhola SL; Jan Ossenkoppele G; Vellenga E; van den Berg-de Ruiter E; Schanz U; Verhoef G; Vandenberghe P; Ferrant A; Köhne CH; Pfreundschuh M; Horst HA; Koller E; von Lilienfeld-Toal M; Bentz M; Ganser A; Schlegelberger B; Jotterand M; Krauter J; Pabst T; Theobald M; Schlenk RF; Delwel R; Döhner K; Löwenberg B; Döhner H
J Clin Oncol; 2010 Aug; 28(24):3890-8. PubMed ID: 20660833
[TBL] [Abstract][Full Text] [Related]
11. IRF2-INPP4B-mediated autophagy suppresses apoptosis in acute myeloid leukemia cells.
Zhang F; Li J; Zhu J; Liu L; Zhu K; Cheng S; Lv R; Zhang P
Biol Res; 2019 Mar; 52(1):11. PubMed ID: 30876449
[TBL] [Abstract][Full Text] [Related]
12. High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities.
Gröschel S; Lugthart S; Schlenk RF; Valk PJ; Eiwen K; Goudswaard C; van Putten WJ; Kayser S; Verdonck LF; Lübbert M; Ossenkoppele GJ; Germing U; Schmidt-Wolf I; Schlegelberger B; Krauter J; Ganser A; Döhner H; Löwenberg B; Döhner K; Delwel R
J Clin Oncol; 2010 Apr; 28(12):2101-7. PubMed ID: 20308656
[TBL] [Abstract][Full Text] [Related]
13. INPP4B Is a PtdIns(3,4,5)P3 Phosphatase That Can Act as a Tumor Suppressor.
Kofuji S; Kimura H; Nakanishi H; Nanjo H; Takasuga S; Liu H; Eguchi S; Nakamura R; Itoh R; Ueno N; Asanuma K; Huang M; Koizumi A; Habuchi T; Yamazaki M; Suzuki A; Sasaki J; Sasaki T
Cancer Discov; 2015 Jul; 5(7):730-9. PubMed ID: 25883023
[TBL] [Abstract][Full Text] [Related]
14. The creatine kinase pathway is a metabolic vulnerability in EVI1-positive acute myeloid leukemia.
Fenouille N; Bassil CF; Ben-Sahra I; Benajiba L; Alexe G; Ramos A; Pikman Y; Conway AS; Burgess MR; Li Q; Luciano F; Auberger P; Galinsky I; DeAngelo DJ; Stone RM; Zhang Y; Perkins AS; Shannon K; Hemann MT; Puissant A; Stegmaier K
Nat Med; 2017 Mar; 23(3):301-313. PubMed ID: 28191887
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of high EVI1 expression in AML patients undergoing myeloablative allogeneic hematopoietic stem cell transplantation in first CR.
He X; Wang Q; Cen J; Qiu H; Sun A; Chen S; Wu D
Bone Marrow Transplant; 2016 Jul; 51(7):921-7. PubMed ID: 27042849
[TBL] [Abstract][Full Text] [Related]
16. Biological and clinical significance of loss of heterozygosity at the INPP4B gene locus in Japanese breast cancer.
Tokunaga E; Yamashita N; Kitao H; Tanaka K; Taketani K; Inoue Y; Saeki H; Oki E; Oda Y; Maehara Y
Breast; 2016 Feb; 25():62-8. PubMed ID: 26577950
[TBL] [Abstract][Full Text] [Related]
17. SHIP1 is targeted by miR-155 in acute myeloid leukemia.
Xue H; Hua LM; Guo M; Luo JM
Oncol Rep; 2014 Nov; 32(5):2253-9. PubMed ID: 25175984
[TBL] [Abstract][Full Text] [Related]
18. Three novel cytogenetically cryptic EVI1 rearrangements associated with increased EVI1 expression and poor prognosis identified in 27 acute myeloid leukemia cases.
Haferlach C; Bacher U; Grossmann V; Schindela S; Zenger M; Kohlmann A; Kern W; Haferlach T; Schnittger S
Genes Chromosomes Cancer; 2012 Dec; 51(12):1079-85. PubMed ID: 22887804
[TBL] [Abstract][Full Text] [Related]
19. INPP4B is an oncogenic regulator in human colon cancer.
Guo ST; Chi MN; Yang RH; Guo XY; Zan LK; Wang CY; Xi YF; Jin L; Croft A; Tseng HY; Yan XG; Farrelly M; Wang FH; Lai F; Wang JF; Li YP; Ackland S; Scott R; Agoulnik IU; Hondermarck H; Thorne RF; Liu T; Zhang XD; Jiang CC
Oncogene; 2016 Jun; 35(23):3049-61. PubMed ID: 26411369
[TBL] [Abstract][Full Text] [Related]
20. Genetic interactions between INPP4B and RAD50 is prognostic of breast cancer survival.
Chen X; Theobard R; Zhang J; Dai X
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31872854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]